Key Insights

Highlights

Success Rate

81% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

13.6%

3 terminated out of 22 trials

Success Rate

81.3%

-5.3% vs benchmark

Late-Stage Pipeline

14%

3 trials in Phase 3/4

Results Transparency

15%

2 of 13 completed with results

Key Signals

2 with results81% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (3)
P 1 (3)
P 2 (6)
P 3 (3)

Trial Status

Completed13
Unknown3
Withdrawn3
Terminated3

Trial Success Rate

81.3%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT04584658Completed

Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19) Infection (DYADS Study)

NCT04830800Phase 1Completed

A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC (Phase 1)

NCT05097677Completed

Follow-up of Covid-19 Long Term Sequelae

NCT04629703Phase 3Completed

Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects

NCT04456426Withdrawn

Characteristics of Patients With COVID-19 in Meta State, Colombia

NCT04435457Terminated

Cardiovascular Implications of COVID-19

NCT04764422Phase 1Completed

Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in Thailand

NCT04443673Not ApplicableTerminated

Glycine Supplement for Severe COVID-19

NCT04621058Phase 3Completed

Efficacy of Vitamin D Treatment in Mortality Reduction Due to COVID-19.

NCT04374565Phase 2Completed

Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia

NCT04753619Phase 2Unknown

Effectiveness of Niclosamide as Add-on Therapy to the Standard of Care Measures in COVID-19 Management

NCT04665960Completed

Infection Control for Severe Acute Respiratory Syndrome Coronavirus 2

NCT04395716Phase 1Withdrawn

A Study of ResCure™ to Treat COVID-19 Infection

NCT04459702Phase 2Withdrawn

A Study of Combination Therapies to Treat COVID-19 Infection

NCT04385901Not ApplicableCompleted

Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth

NCT04405310Phase 2CompletedPrimary

Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial

NCT04358640Completed

Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey

NCT04445961CompletedPrimary

Respiratory Mechanics and Gas Exchange in Patients With COVID-19 and Hypoxemic Acute Respiratory Failure

NCT04403685Phase 3Terminated

Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers

NCT04357340Not ApplicableCompleted

The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19

Scroll to load more

Research Network

Activity Timeline